Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know

Group 1 - Replimune Group, Inc. (REPL) shares have increased by 0.7% over the past four weeks, closing at $7.76, with a mean price target of $12.86 indicating a potential upside of 65.7% [1] - The average of seven short-term price targets ranges from a low of $10.00 to a high of $19.00, with a standard deviation of $3.02, suggesting a potential increase of 28.9% to 144.9% from the current price [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 3.5% over the past month, indicating positive sentiment about the company's earnings prospects [11][12] Group 2 - REPL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets are often viewed as unreliable indicators, the direction implied by these targets suggests a positive outlook for REPL [14]